Is Pfizer an Excellent Dividend Stock to Buy?
Pfizer has a history of developing treatments that generate billions in sales.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.
More in Finance & Markets
Mumbai Local Train Passengers To Pay Extra ₹5.90 On Railway Tickets And Season Passes Above ₹2,000 Via UPI From October 15
Mumbai: Passengers purchasing railway tickets or suburban season passes worth ₹2,000 or more through UPI will have to pay an additional ₹5.90 from October 15, with the charge comprising ₹5 Merchant…
International Paper Stock: Buy or Sell in September?
Despite rising input costs, management is finding ways to improve margins.
The U.S. Central Bank Delivers Massive News to Stock Market Investors
The opportunity cost of capital is increasing, and investors need to consider the implications.
What's Going on With Planet Labs Stock?
Increasing geopolitical tensions have boosted demand for Planet Labs' products.
AbbVie's Migraine Franchise Scored a Big Win. Is This Dividend King a No-Brainer Buy Right Now?
AbbVie's market-beating days don't seem to be over yet.